HOME >> BIOLOGY >> NEWS
Magnetic field exposure associated with childhood leukemia

Researchers at the University of Toronto and the Hospital for Sick Children have found an association between magnetic field exposures in residences and the risk of developing childhood leukemia.

The study, reported in two separate papers in the current issues of the International Journal of Cancer (IJC) and the journal Cancer Causes and Control (CCC), shows that children with higher exposures to magnetic fields in residences are two to four times more likely to develop leukemia compared to children who are less exposed. The study comprehensively measured magnetic field exposures inside and outside the children's homes. Wire code was also assigned to each residence. For some children, EMF exposures were measured by a personal monitor.

The authors report in IJC that overall, wire code -- a surrogate indicator of magnetic field exposure based on the physical characteristics of the line and proximity of the residence to power lines -- was not associated with an increased risk of developing leukemia. However, leukemia risk was elevated for children diagnosed at less than six years of age in relation to magnetic field exposures in residences occupied during the first two years of life.

A subset of the total study population wore a personal monitoring device which measured EMF during usual activities in the home over 48 hours. As reported in CCC, exposure to magnetic fields was associated with a two-fold increase in risk of developing leukemia.

When other factors such as residential mobility, power consumption, child's medical history and other environmental exposures were taken into account, children exposed to higher levels of magnetic fields were 4.5 times more likely to develop leukemia compared to less exposed children. Risks were higher for children diagnosed at less than six years of age and for those with acute lymphoblastic leukemia -- the most common type of leukemia in children.

"As t
'"/>

Contact: Steven de Sousa
steven.desousa@utoronto.ca
416-978-5949
University of Toronto
16-Jun-1999


Page: 1 2

Related biology news :

1. Magnetic tag lets scientists track stem cells in living rat
2. Magnetic fluids offer hope for treatment of retinal detachment
3. Magnetic fields may hold key to malaria treatment, UW researchers find
4. Magnetic resonance imaging of sexual intercourse is both possible and useful...
5. Magnetic Fluids More Complex Than Previously Thought
6. Report On Electrical And Magnetic Fields Released; Public Invited To Comment At Regional Meetings
7. Scientists Use Magnetic Field As Alternative To Space-Based Zero Gravity
8. Moving DNA Molecules With Magnetic Tweezers
9. Newly Discovered Bacteria Produce Magnetic Material
10. Health of worlds sea lions the focus of Wakefield Symposium
11. From orchards and fields to townhouses and offices

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Magnetic field exposure associated with childhood leukemia

(Date:10/17/2014)... – Accurate knowledge regarding Ebola is critical and pertinent ... of hazardous global outbreak and epidemic. The Journal, ... a special issue, Ebola Virus and Public Health, to ... knowledge in this critical societal moment. , On ... Ebola for Clinicians . The primer was prepared by ...
(Date:10/17/2014)... This news release is available in German . ... for only a very few drugs. When treating overdoses, doctors ... Treatment is especially difficult if there is a combination of ... is playing and accidentally swallows his grandmother,s pills? ETH professor ... Zurich wanted to find an answer to this question. "The ...
(Date:10/16/2014)... managers have a new synthesis of recent research findings ... forests in the two states. , The Ecology ... and Washington: A Synthesis of the Relevant Biophysical Science ... report published by the U.S. Forest Service,s Pacific Northwest ... from managers for a synthesis of the large body ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2
(Date:10/22/2014)... -- Nuvilex, Inc. (OTCQB: NVLX) – According to the ... living with diabetes, with  that number expected to grow ... for diabetes treatments is approximately $500 billion.  ... pancreatic cancer.  Pancreatic cancer is the fourth most common ... the United States , and according to a ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market by ... Systems, Table-top Counters) by End-user (Inpatient Pharmacy Automation, ... to 2019” analyzes and studies the major market ... Asia-Pacific, and the Rest of the World (RoW). ... spread through 300 pages and in-depth TOC on ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: